dc.creatorKornuta, Claudia Alejandra
dc.creatorCheuquepan Valenzuel, Felipe Andres
dc.creatorBidart, , Juan Esteban
dc.creatorSoria, Ivana
dc.creatorGammella, Mariela
dc.creatorQuattrocchi, Valeria
dc.creatorHecker, Yanina
dc.creatorMoore, Prando Dadin
dc.creatorRomera, Sonia Alejandra
dc.creatorMarin, Maia Solange
dc.creatorZamorano, Patricia Ines
dc.creatorLangellotti, Cecilia Ana
dc.date.accessioned2021-12-10T17:07:29Z
dc.date.accessioned2023-03-15T14:12:33Z
dc.date.available2021-12-10T17:07:29Z
dc.date.available2023-03-15T14:12:33Z
dc.date.created2021-12-10T17:07:29Z
dc.date.issued2022-01
dc.identifier0042-6822
dc.identifierhttps://doi.org/10.1016/j.virol.2021.11.014
dc.identifierhttp://hdl.handle.net/20.500.12123/10887
dc.identifierhttps://www.sciencedirect.com/science/article/abs/pii/S0042682221002397
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6213854
dc.description.abstractThe innate and acquired immune response induced by a commercial inactivated vaccine against Bovine Herpesvirus-1 (BoHV-1) and protection conferred against the virus were analyzed in cattle. Vaccination induced high levels of BoHV-1 antibodies at 30, 60, and 90 days post-vaccination (dpv). IgG1 and IgG2 isotypes were detected at 90 dpv, as well as virus-neutralizing antibodies. An increase of anti-BoHV-1 IgG1 in nasal swabs was detected 6 days post-challenge in vaccinated animals. After viral challenge, lower virus excretion and lower clinical score were observed in vaccinated as compared to unvaccinated animals, as well as BoHV-1-specific proliferation of lymphocytes and production of IFNγ, TNFα, and IL-4. Downregulation of the expression of endosome Toll-like receptors 8–9 was detected after booster vaccination. This is the first thorough study of the immunity generated by a commercial vaccine against BoHV-1 in cattle.
dc.languageeng
dc.publisherElsevier
dc.relationinfo:eu-repograntAgreement/INTA/PNBIO-1131032/AR./Desarrollo de herramientas biotecnológicas para la prevención y el control de enfermedades pecuarias: vacunas, diagnóstico y eIdemiología molecular.
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.sourceVirology 566 : 98-105 (January 2022)
dc.subjectGanado Bovino
dc.subjectEnfermedades de los Animales
dc.subjectRespuesta Inmunológica
dc.subjectVacuna
dc.subjectHerpes Virus Bovino
dc.subjectVacuna Inactivada
dc.subjectCattle
dc.subjectAnimal Diseases
dc.subjectImmune Response
dc.subjectVaccines
dc.subjectBovine Herpesvirus
dc.subjectInactivated Vaccines
dc.titleTLR activation, immune response and viral protection elicited in cattle by a commercial vaccine against Bovine Herpesvirus-1
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion


Este ítem pertenece a la siguiente institución